Global prenatal testing market 2014 2018

Major Players. Furthermore, due to the availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of North America NIPT market throughout the forecast period.

Us nipt market size

The presence of major market players, such as Abbott Laboratories Inc. Moreover, there is less delineation between high and average risk, which is expected to enhance the volumetric capabilities. The advent of next-generation sequencing has also expanded the market studied in various fields, as it has brought a major increase in throughput capacity through automation, which ultimately leads to faster turnaround time and reduction in costs. Regional Insights North America accounted for the major share in The product advancements and improvements in genetic testing platforms by the major players are increasing competitive rivalry. China is expected to remain a significant opportunity for non-invasive prenatal screening, with nearly 16 million annual births out of which around , fall under the category of high risk pregnancies. These participants are engaged in the development and licensing of the software and cloud distribution model to enhance technology transfer. Report Scope. Presence of payers such as Anthem and Blue Shield of California that have endorsed DNA-based NIPT screening for trisomy 13, 18, and 21 is expected to impact the adoption rate of these tests, thereby resulting to growth in the revenue generation. Major Players. Development of NIPT for genetic conditions is a major commercial interest owing to high demand in the disease segments such as Down Syndrome. Several companies have focused on the analysis of cffDNA in a sample of maternal blood collected in the first trimester to develop a more accurate and reliable NIPT.

China is expected to remain a significant opportunity for non-invasive prenatal screening, with nearly 16 million annual births out of which aroundfall under the category of high risk pregnancies.

The growth in this market is attributed to the accelerated customer adoption of NIPT procedures coupled with the expansion in the distribution services of the operating entities which enables them to materially capture the potential NIPT opportunity. Evolution of prenatal testing, in the form of non-invasive tests that can serve as an intermediate step between screening and invasive tests in order to determine the probability of fetal abnormality is expected to drive growth in the reproductive genetics industry over the forecast period.

Development of NIPT for genetic conditions is a major commercial interest owing to high demand in the disease segments such as Down Syndrome. Development of NIPT for genetic conditions is a major commercial interest owing to high demand in the disease segments such as Down Syndrome.

Report scope can be customized per your requirements. The growth in this market is attributed to the accelerated customer adoption of NIPT procedures coupled with the expansion in the distribution services of the operating entities which enables them to materially capture the potential NIPT opportunity.

Natera

The growth in this market is attributed to the accelerated customer adoption of NIPT procedures coupled with the expansion in the distribution services of the operating entities which enables them to materially capture the potential NIPT opportunity. In the past, the Federal Trade Commission FTC has also played a role in regulating genetic testing companies who advertised false and misleading claims about their products, but this agency currently plays a more minor role in this space. Report Scope. Moreover, there is less delineation between high and average risk, which is expected to enhance the volumetric capabilities. Click here. Molecular genetic testing can be used to diagnose many of the genetic disorders, but this type of technology may not be appropriate for diagnosis of all the genetic conditions. In addition to this, coverage expansion by the payers into average-risk pregnancies over the forecast period in order to realize savings on amniocentesis and the treatment of Down's Syndrome is anticipated to enhance the penetration of non-invasive prenatal testing products, consequently influencing revenue generation in this vertical. Furthermore, due to the availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of North America NIPT market throughout the forecast period. Gestation Period Insights Highly accurate results are gained by the virtue of screening in the first trimester i. Factors that attribute the large share include presence of the favorable payor reimbursement in this segment coupled with the rising awareness pertaining to the prevention of occurrence of chromosomal anomalies such as Downs Syndrome. Risk Type Insights The market is well penetrated with respect to high risk, however, there are few payers that do not have favorable medical coverage decisions for average risk testing. Presence of payers such as Anthem and Blue Shield of California that have endorsed DNA-based NIPT screening for trisomy 13, 18, and 21 is expected to impact the adoption rate of these tests, thereby resulting to growth in the revenue generation. The product advancements and improvements in genetic testing platforms by the major players are increasing competitive rivalry.

Presence of payers such as Anthem and Blue Shield of California that have endorsed DNA-based NIPT screening for trisomy 13, 18, and 21 is expected to impact the adoption rate of these tests, thereby resulting to growth in the revenue generation. The companies are focusing on gaining the characteristics of both rapid growth equipment companies and emerging lab companies in order to gain the larger share of revenue.

Report Scope. Furthermore, due to the availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of North America NIPT market throughout the forecast period.

nipt testing companies

Gestation Period Insights Highly accurate results are gained by the virtue of screening in the first trimester i.

Rated 10/10 based on 2 review
Download
Genetic Testing Market